Genomics in Scotland strategy: island communities impact assessment

Performance measurement

Governance and progress will be overseen by the Scottish Government, with progress reports published annually. The Scottish Strategic Network for Genomic Medicine (SSNGM), with an oversight board, steering group, and patient involvement advisory group, will provide expertise, support, and advice on actions and general direction of travel. Responsibility for delivery of actions will sit across many delivery partners including the Scottish Government, NHS Boards and the SSNGM. The ‘Once for Scotland’ approach will be a core principle with national decisions and implementation made wherever possible for work that is universally applicable across Scotland.

Further detail of each phase of implementation will be published throughout the term of the strategy, with the initial one-year implementation plan available alongside the launch of the strategy. As part of delivery, we will also develop a set of performance measures to monitor and report on both the implementation of the strategy and the overall delivery of genomic medicine services in Scotland.

This impact assessment should be read in conjunction with assessments developed in parallel, including:

• Equality Impact Assessment (EQIA)
• Children’s Rights and Wellbeing Impact Assessment (CRWIA)
• Business and Regulatory Impact Assessment (BRIA)
• Fairer Scotland Duty (FSD)
• Strategic Environment Assessment (SEA) screen